CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- 4 Open-market sale EVP of Research sold 5,000 shares at $18.30 ($91,500)
- 4 Open-market sale Chief Business Officer sold 22,500 shares at $17.81 ($400,725)
- 4 Open-market sale Chief Medical Officer sold 5,000 shares at $15.85 ($79,250)
- 4 Open-market sale Chief Medical Officer sold 45,000 shares at $16.03 ($721,350)
- 4 Open-market sale Chief Business Officer sold 5,000 shares at $16.01 ($80,050)
- 4 Open-market sale Chief Business Officer sold 5,000 shares at $13.86 ($69,300)
- 4 Open-market sale Chief Business Officer sold 5,000 shares at $13.76 ($68,800)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 4,500 shares at an average $11.23 ($50,529)
- 4 Open-market buy Ex VP, Intern'l Operations bought 9,900 shares at $10.07 ($99,739)
- 4 Open-market buy Chief Executive Officer bought 5,125 shares at an average $10.71 ($54,891)
- 4 Exercise or conversion Chief Business Officer acquired 20,000 shares (option exercise)
Page 8 of 10 · 184 filings